No cytotoxic and inflammatory effects of empagliflozin and dapagliflozin on primary renal proximal tubular epithelial cells under diabetic conditions in vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International journal of molecular sciences, 21.2020, Nr. 2, Art. 391, doi:10.3390/ijms21020391
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2020
- Urheber
- URN
-
urn:nbn:de:hebis:30:3-542901
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Baer, Patrick
- Koch, Benjamin
- Freitag, Janina
- Schubert, Ralf
- Geiger, Helmut
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2020
Ähnliche Objekte (12)
Antigen Cross-Presentation by Murine Proximal Tubular Epithelial Cells Induces Cytotoxic and Inflammatory CD8+ T Cells
Metabolic mechanisms of acute proximal tubular injury
Ex vivo analysis of renal proximal tubular cells
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction
Dapagliflozin
New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Role of EHD1 in Renal Proximal Tubular Endocytosis and Recycling
Streptozotocin induces renal proximal tubular injury through p53 signaling activation
Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients
Antigen Cross-Presentation by Murine Proximal Tubular Epithelial Cells Induces Cytotoxic and Inflammatory CD8+ T Cells
Metabolic mechanisms of acute proximal tubular injury
Ex vivo analysis of renal proximal tubular cells
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction
Dapagliflozin
New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Role of EHD1 in Renal Proximal Tubular Endocytosis and Recycling
Streptozotocin induces renal proximal tubular injury through p53 signaling activation
Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients
Antigen Cross-Presentation by Murine Proximal Tubular Epithelial Cells Induces Cytotoxic and Inflammatory CD8+ T Cells
Metabolic mechanisms of acute proximal tubular injury
Ex vivo analysis of renal proximal tubular cells
Empagliflozin’s role in early tubular protection for type 2 diabetes patients
Effects of Empagliflozin and Dapagliflozin in alleviating cardiac fibrosis through SIRT6-mediated oxidative stress reduction
Dapagliflozin
New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation
Study comparing the efficacy and renal safety for patients with diabetes switching from dapagliflozin to empagliflozin
Role of EHD1 in Renal Proximal Tubular Endocytosis and Recycling
Streptozotocin induces renal proximal tubular injury through p53 signaling activation
Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study